High Vista Strategies LLC Regenxbio Inc. Transaction History

High Vista Strategies LLC

  • $249 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$22.29 - $35.04 $297,437 - $467,573
13,344 Added 81.6%
29,696 $785,000
Q2 2022

Aug 15, 2022
BUY
$19.35 - $35.04 $316,411 - $572,974
16,352 New
16,352 $404,000
Q1 2022

May 16, 2022
SELL
$24.62 - $34.31 $732,518 - $1.02 Million
-29,753 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$30.19 - $40.28 $898,243 - $1.2 Million
29,753 New
29,753 $973,000

Others Institutions Holding RGNX

# of Institutions
193
Shares Held
43.5M
Call Options Held
58.9K
Put Options Held
58.4K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $404M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email